WOLF GREGORY H 4
4 · MICRUS ENDOVASCULAR CORP · Filed Sep 28, 2010
Insider Transaction Report
Form 4
WOLF GREGORY H
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2010-09-27$9.94/sh−10,000$99,400→ 0 totalExercise: $13.46Exp: 2019-09-15→ Common Stock (10,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2010-09-27$5.89/sh−10,000$58,900→ 0 totalExercise: $17.51Exp: 2017-11-12→ Common Stock (10,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2010-09-27$5.72/sh−25,000$143,000→ 0 totalExercise: $17.68Exp: 2016-11-14→ Common Stock (25,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2010-09-27$10.56/sh−10,000$105,600→ 0 totalExercise: $12.84Exp: 2018-09-16→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]Pursuant to the Agreement and Plan of Merger, dated as of July 11, 2010, between Micrus Endovascular Corporation, Johnson & Johnson and Cope Acquisition Corp., this stock option was converted into the right to receive an amount in cash per share subject to the stock option equal to the excess of the per share merger consideration of $23.40 over the per share exercise price of such stock option, without interest.